Intrinsic Value of S&P & Nasdaq Contact Us

Eco-Growth Strategies Inc. ECGS OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
8/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Eco-Growth Strategies Inc. (ECGS) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.15. It has a SharesGrow Score of 8/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net income is $1M (loss), growing at -80.4%/yr. Net profit margin is 0% (thin). Gross margin is 12.5% (+0 pp trend).

Balance sheet: total debt is $6M with negative equity of -$8M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.6 (tight liquidity). Debt-to-assets is 461.3%. Total assets: $1M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 0/100 (Fail), Moat 18/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

ECGS SharesGrow Score Overview

17/100
SharesGrow Score
Weak fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 18/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.051-0.795
Volume43.38K
Avg Volume (30D)114.18K
Market Cap$6.3M
Beta (1Y)-4.05
Share Statistics
EPS (TTM)-0.02
Shares Outstanding$55.3M
IPO Date2021-01-08
CEOWilliam J. Delgado
Financial Highlights & Ratios
Gross Profit$-67.5K
EBITDA$-1.19M
Net Income$-1.26M
Operating Income$-1.26M
Total Cash$5.15K
Total Debt$6.2M
Net Debt$6.19M
Total Assets$1.34M
Price / Earnings (P/E)-6.6
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS27890J1043

Price Chart

ECGS
Eco-Growth Strategies Inc.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.05 52WK RANGE 0.80
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message